Mahesh Karande - Feb 28, 2023 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGA)

Role
President and CEO, Director
Signature
/s/ Barbara Chan as Attorney-in-Fact for Mahesh Karande
Stock symbol
OMGA
Transactions as of
Feb 28, 2023
Transactions value $
$0
Form type
4
Date filed
3/2/2023, 03:05 PM
Previous filing
Oct 28, 2022
Next filing
Feb 9, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Option (Right to Buy) Award $0 +170K $0.00 170K Feb 28, 2023 Common Stock 170K $6.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable with respect to 25% of the underlying shares on February 28, 2024 and in equal quarterly installments thereafter such that the option will become fully vested and exercisable on February 28, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.